Screener
Globus Medical GMED Amortized cost of available-for-sale debt securities, current
Amortized cost of available-for-sale debt securities, current at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent.
The source filing: Globus Medical’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054450
| (In thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |
|---|---|---|---|---|
| Corporate debt securities | 2,387 | — | (3) | 2,384 |
| Commercial paper | 63,926 | 1 | (26) | 63,901 |
| Government, federal agency, and other sovereign obligations | 11,267 | — | (27) | 11,240 |
| Total short-term marketable securities | $87,461 | $1 | $(65) | $87,397 |
| Long-term: | ||||
| Municipal bonds | $3,400 | $2 | $(18) | $3,384 |
| Corporate debt securities | 101,773 | — | (618) | 101,155 |
| Asset-backed securities | 104,237 | 17 | (466) | 103,788 |
Item 1. Financial Statements
FAQ
- What is Globus Medical's amortized cost of available-for-sale debt securities, current?
- Globus Medical (GMED) reported amortized cost of available-for-sale debt securities, current of $87.46M in Q2 2026.
- What is the long-term trend for Globus Medical's amortized cost of available-for-sale debt securities, current?
- Over 4 years (2021 to 2025), Globus Medical's amortized cost of available-for-sale debt securities, current has grown at a -40.6% compound annual growth rate (CAGR), from $249.9M to $31.07M.
- What does amortized cost of available-for-sale debt securities, current mean?
- Amortized cost of available-for-sale debt securities, current
Ask your AI about Globus Medical's amortized cost of available-for-sale debt securities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude